201 related articles for article (PubMed ID: 31561960)
1. Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm.
Tremoulet AH; Jain S; Jone PN; Best BM; Duxbury EH; Franco A; Printz B; Dominguez SR; Heizer H; Anderson MS; Glodé MP; He F; Padilla RL; Shimizu C; Bainto E; Pancheri J; Cohen HJ; Whitin JC; Burns JC
J Pediatr; 2019 Dec; 215():107-117.e12. PubMed ID: 31561960
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms.
Niedra E; Chahal N; Manlhiot C; Yeung RS; McCrindle BW
Pediatr Cardiol; 2014 Jan; 35(1):89-92. PubMed ID: 23864222
[TBL] [Abstract][Full Text] [Related]
3. Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial.
Yang J; Jain S; Capparelli EV; Best BM; Son MB; Baker A; Newburger JW; Franco A; Printz BF; He F; Shimizu C; Hoshino S; Bainto E; Moreno E; Pancheri J; Burns JC; Tremoulet AH
J Pediatr; 2022 Apr; 243():173-180.e8. PubMed ID: 34953816
[TBL] [Abstract][Full Text] [Related]
4. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
Tremoulet AH; Jain S; Kim S; Newburger J; Arditi M; Franco A; Best B; Burns JC
Contemp Clin Trials; 2016 May; 48():70-5. PubMed ID: 27080929
[TBL] [Abstract][Full Text] [Related]
5. [Kawasaki disease in children--9 years experience].
Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
[TBL] [Abstract][Full Text] [Related]
6. miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.
He M; Chen Z; Martin M; Zhang J; Sangwung P; Woo B; Tremoulet AH; Shimizu C; Jain MK; Burns JC; Shyy JY
Circ Res; 2017 Jan; 120(2):354-365. PubMed ID: 27923814
[TBL] [Abstract][Full Text] [Related]
7. A phase I/IIa trial of atorvastatin in Japanese patients with acute Kawasaki disease with coronary artery aneurysm: Study protocol of a multicenter, single-arm, open-label trial.
Murata Y; Isayama R; Imai S; Shoji K; Youndzi M; Okada M; Mikami M; Kobayashi S; Urayama KY; Kobayashi T
Contemp Clin Trials Commun; 2022 Apr; 26():100892. PubMed ID: 35198792
[TBL] [Abstract][Full Text] [Related]
8. [Safety of warfarin therapy in children with coronary aneurysm due to Kawasaki disease].
He XH; Zhu QL; Yuan YH; Long XD; Xia XH; Wang S; Hu C
Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):95-100. PubMed ID: 33548954
[No Abstract] [Full Text] [Related]
9. Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
Kim GB; Yu JJ; Yoon KL; Jeong SI; Song YH; Han JW; Hong YM; Joo CU
J Pediatr; 2017 May; 184():125-129.e1. PubMed ID: 28043685
[TBL] [Abstract][Full Text] [Related]
10. Time Course of Coronary Artery Aneurysms in Kawasaki Disease.
Tsuda E; Hashimoto S
J Pediatr; 2021 Mar; 230():133-139.e2. PubMed ID: 33301786
[TBL] [Abstract][Full Text] [Related]
11. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
[TBL] [Abstract][Full Text] [Related]
12. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
Abushaban L; Salama A; Uthaman B; Kumar A; Selvan J
Int J Cardiol; 1999 Apr; 69(1):71-6. PubMed ID: 10362375
[TBL] [Abstract][Full Text] [Related]
13. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
[TBL] [Abstract][Full Text] [Related]
14. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms.
Halyabar O; Friedman KG; Sundel RP; Baker AL; Chang MH; Gould PW; Newburger JW; Son MBF
Pediatr Rheumatol Online J; 2021 Mar; 19(1):31. PubMed ID: 33731148
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.
Abbasi SH; Mohammadinejad P; Shahmansouri N; Salehiomran A; Beglar AA; Zeinoddini A; Forghani S; Akhondzadeh S
J Affect Disord; 2015 Sep; 183():149-55. PubMed ID: 26005776
[TBL] [Abstract][Full Text] [Related]
17. High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease.
Salgado AP; Ashouri N; Berry EK; Sun X; Jain S; Burns JC; Tremoulet AH
J Pediatr; 2017 Jun; 185():112-116.e1. PubMed ID: 28408126
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac manifestations in the acute phase of Kawasaki disease in a third level children's hospital in Mexico City].
Garrido-García LM; Peña-Juárez RA; Yamazaki-Nakashimada MA
Arch Cardiol Mex; 2018 Dec; 88(5):441-446. PubMed ID: 29650328
[TBL] [Abstract][Full Text] [Related]
19. ATYPICAL KAWASAKI DISEASE.
Ristovski L; Milankov O; Vislavski M; Savić R; Bjelica M
Med Pregl; 2016; 69(1-2):53-7. PubMed ID: 27498535
[TBL] [Abstract][Full Text] [Related]
20. Safety Outcomes of Atorvastatin 80 mg Versus Atorvastatin 40 mg in a Veteran Population.
Jacobs D; Wassell K; Guidry TJ; Sullivan J
Ann Pharmacother; 2020 Feb; 54(2):151-156. PubMed ID: 31544472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
